VaishaliMankadMD
Allergy & Immunology • Durham, NCGlobal Development Medical Director, Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca
Dr. Mankad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4309 Emperor Boulevard
Suite 400
Durham, NC 27703
Education & Training
Duke University HospitalFellowship, Allergy and Immunology, 2003 - 2005- Duke University HospitalResidency, Pediatrics, 1998 - 2001
University of Illinois College of MedicineClass of 1998
Certifications & Licensure
NC State Medical License 2001 - 2025
VA State Medical License 2007 - 2010- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- AoA AoA
Publications & Presentations
PubMed
- Lower respiratory tract infections following respiratory syncytial virus monoclonal antibody nirsevimab immunization versus placebo: Analysis from a Phase 3 randomized...Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk, Bahar Ahani, Yue Chang
Clinical Infectious Diseases. 2024-12-04 - Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 r...Kevin M Tuffy, Bahar Ahani, Joseph B Domachowske, Kenji Furuno, Hong Ji
Vaccine. 2024-10-24 - 1 citationsSafety and Pharmacokinetics of Nirsevimab in Immunocompromised Children.Joseph Domachowske, Ulrika Wählby Hamrén, Irfana Banu, Roberta Baronio, Bhanu Basavaraju
Pediatrics. 2024-10-01
Professional Memberships
- Member
Industry Relationships
- Global Development Medical Director, AstraZenecaLate phase clinical developmentDisclosure: Employee2020 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
